Transcriptional upregulation of multidrug resistance-associated protein 4 (MRP4) by Nrf2 activators does not require Nrf2 participation

被引：0
|
作者：
Tan, Kah Poh
Ito, Shinya
机构：
[1] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[2] Hosp Sick Children, Integrat Biol Program, Div Clin Pharmacol, Toronto, ON M5G 1X8, Canada
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
386
引用
收藏
页码：251 / 252
页数：2
相关论文
共 50 条
  • [21] Regulation of Linaclotide-Induced cGMP and Electrolyte Secretion by Multidrug Resistance-Associated Protein 4 (MRP4)
    Tchernychev, Boris
    Ge, Pei
    Wachtel, Derek
    Solinga, Robert
    Kessler, Marco
    Ranganath, Sheila
    Hannig, Gerhard
    Silos-Santiago, Inmaculada
    GASTROENTEROLOGY, 2015, 148 (04) : S735 - S735
  • [22] Regulation of redox processes in biological systems with the participation of the Keap1/Nrf2/ARE signaling pathway, biogenic selenium nanoparticles as Nrf2 activators
    Bityutsky, V. S.
    Tsekhmistrenko, S., I
    Tsekhmistrenko, O. S.
    Tymoshok, N. O.
    Spivak, M. Y.
    REGULATORY MECHANISMS IN BIOSYSTEMS, 2020, 11 (04) : 483 - 493
  • [23] The modulation of transcriptional expression and inhibition of multidrug resistance associated protein 4 (MRP4) by analgesics and their primary metabolites
    Scialis, Renato J.
    Ghanem, Carolina, I
    Manautou, Jose E.
    CURRENT RESEARCH IN TOXICOLOGY, 2020, 1 : 34 - 41
  • [24] Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity
    Liu, Chengcheng
    Janke, Laura J.
    Yang, Jun J.
    Evans, William E.
    Schuetz, John D.
    Relling, Mary V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (02) : 287 - 293
  • [25] The Multidrug Resistance-Associated Protein 4 (MRP4) Appears as a Functional Carrier of Prostaglandins Regulated by Oxytocin in the Bovine Endometrium
    Lacroix-Pepin, Nicolas
    Danyod, Ghislain
    Krishnaswamy, Narayanan
    Mondal, Sukanta
    Rong, Pei-Min
    Chapdelaine, Pierre
    Fortier, Michel A.
    ENDOCRINOLOGY, 2011, 152 (12) : 4993 - 5004
  • [26] Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity
    Chengcheng Liu
    Laura J. Janke
    Jun J. Yang
    William E. Evans
    John D. Schuetz
    Mary V. Relling
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 287 - 293
  • [27] Multidrug resistance-associated protein 4 (MRP4) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia
    Brueggemann, Monika
    Trautmann, Heiko
    Hoelzer, Dieter
    Kneba, Michael
    Goekbuget, Nicola
    Raff, Thorsten
    BLOOD, 2009, 114 (26) : 5400 - 5401
  • [28] Nrf2 Pathway Regulates Multidrug-Resistance-Associated Protein 1 in Small Cell Lung Cancer
    Ji, Lili
    Li, Hui
    Gao, Pan
    Shang, Guoguo
    Zhang, Donna D.
    Zhang, Nong
    Jiang, Tao
    PLOS ONE, 2013, 8 (05):
  • [29] Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers
    Tian, Xianbin
    Swift, Brandon
    Zamek-Gliszczynski, Maciej J.
    Belinsky, Martin G.
    Kruh, Gary D.
    Brouwer, Kim L. R.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (05) : 911 - 915
  • [30] An Update on the Role of Nrf2 and its Activators in Diseases Associated with Oxidative Stress
    Sugumar, Deepa
    Saravanan, J.
    Emdormi, R.
    Praveen, T. K.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 (02) : 184 - 192
12345